Acute Efficacy and 6 Months Follow up After Electroconvulsive Therapy
NCT05388461 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 600
Last updated 2023-09-26
Summary
The overall aim of the current project is to assess the acute and long term outcome of ECT (both patient and clinician rated) in a non-selected patient cohort from ordinary clinical activity, and to seek out factors predicting response and remission, side effects and relapse.
Conditions
- Depressive Disorder
Interventions
- OTHER
-
electroconvulsive therapy
electroconvulsive therapy
Sponsors & Collaborators
-
Helse Stavanger HF
collaborator OTHER_GOV -
Haukeland University Hospital
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-03-13
- Primary Completion
- 2028-12-31
- Completion
- 2028-12-31
Countries
- Norway
Study Locations
More Related Trials
-
Predictors of the Response and Relapse/Recurrence After ECT for Depressed Patients
NCT02032576 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Electrophysiological Markers of Antidepressants in Major Depressive Disorder
NCT06532604 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Changing Tactics? Optimizing ECT in Difficult-to-treat Depression
NCT05923801 ·Status: RECRUITING ·Phase: NA
-
Continuation Electroconvulsive Therapy (C-ECT) for Relapse Prevention in Major Depression
NCT01305707 ·Status: TERMINATED ·Phase: PHASE4
-
Preventing Relapse After Successful Electroconvulsive Therapy for Depression
NCT06751875 ·Status: COMPLETED ·Phase: NA
-
ELEKT-D: Electroconvulsive Therapy (ECT) vs. Ketamine in Patients With Treatment Resistant Depression (TRD)
NCT03113968 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Ketamine Augmentation of ECT in Treatment-Resistant Depression
NCT07088380 ·Status: RECRUITING ·Phase: PHASE3
-
Enhancing the Effectiveness of Electroconvulsive Therapy in Severe Depression
NCT01907217 ·Status: COMPLETED ·Phase: PHASE4
-
Relapse Prevention With Escitalopram or Nortriptyline Following Electro-Convulsive Treatment (DUAG-7)
NCT00660062 ·Status: TERMINATED ·Phase: PHASE4
-
Ketamine as an Alternative Treatment to ECT in Major Depressive Disorder
NCT02659085 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Study of Participants With Moderate or Severe Major Depressive Disorder (MDD) Requiring Urgent Symptom Control in a Psychiatric Emergency
NCT04829669 ·Status: WITHDRAWN
-
Study on the Influence of Electroconvulsive Therapy (ECT) on Homocysteine Levels
NCT00370058 ·Status: COMPLETED ·Phase: PHASE4
-
Optimizing Electroconvulsive Therapy for Depression
NCT00045916 ·Status: COMPLETED ·Phase: PHASE4
-
Ketamine Versus Electroconvulsive Therapy in Depression
NCT03674671 ·Status: SUSPENDED ·Phase: PHASE3
-
Imaging Predictors of Treatment Response in Depression
NCT00367341 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of MK-1942 When Added to Stable Antidepressant Therapy in Participants With Treatment-Resistant Depression (TRD) (MK-1942-006)
NCT04663321 ·Status: TERMINATED ·Phase: PHASE2
-
Effects of Electroconvulsive Therapy (ECT) on Serotonin-1A Receptor Binding
NCT00922064 ·Status: COMPLETED ·Phase: PHASE4
-
Comparative Effectiveness of ECT vs. KETAMINE Over the Lifespan
NCT06034821 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE4
-
Electroconvulsive Therapy and Concomitant Lithium in Depressive Disorder: A Pilot Study
NCT05923476 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Quantitative Electroencephalogram (QEEG) Predictors of Response to Psychotherapy Versus Antidepressant Treatment in Depression
NCT00824044 ·Status: COMPLETED ·Phase: PHASE4
-
Esketamine vs ECT for Acute Suicidality
NCT06355180 ·Status: COMPLETED ·Phase: NA
-
Ketamine Anesthesia for Improvement of Depression in ECT
NCT02752724 ·Status: COMPLETED ·Phase: NA
-
Characterization of Microbial, Immune and Epigenetic Biomarkers for Major Depressive Disorder and ECT Treatment
NCT03703414 ·Status: UNKNOWN
-
Electrophysiologic Parameters and Biomarkers Predicting Treatment Response in Patients With Major Depressive Disorder
NCT01997580 ·Status: UNKNOWN ·Phase: PHASE4
-
Ketamine for Depression Relapse Prevention Following ECT
NCT02414932 ·Status: COMPLETED ·Phase: EARLY_PHASE1